Journal of Preventive Medicine and Public Health

  • 제41권6호
  • /
  • Pages.373-379
  • /
  • 2008
  • /
  • 1975-8375(pISSN)
  • /
  • 2233-4521(eISSN)
대한예방의학회 (The Korean Society for Preventive Medicine)
권호 표지
DOI QR코드

DOI QR Code

한 농촌지역 주민에서 성, 연령 및 Helicobacter pylori 감염 여부에 따른 위축성 위염과 장상피화생 유병률

The Prevalence of Atrophic Gastritis and Intestinal Metaplasia according to Gender, Age and Helicobacter Pylori Infection in a Rural Population

  • 김현자 (한양대학교 의과대학 예방의학교실) ;
  • 최보율 (한양대학교 의과대학 예방의학교실) ;
  • 변태준 (한양대학교 의과대학 내과학교실) ;
  • 은창수 (한양대학교 의과대학 내과학교실) ;
  • 송규상 (충남대학교 의과대학 병리학교실) ;
  • 김용성 (한국생명공학연구원 유전체의학연구센터) ;
  • 한동수 (한양대학교 의과대학 내과학교실)
  • Kim, Hyun-Ja (Department of Preventive Medicine, Hanyang University College of Medicine) ;
  • Choi, Bo-Youl (Department of Preventive Medicine, Hanyang University College of Medicine) ;
  • Byun, Tae-Joon (Department of Internal Medicine, Hanyang University College of Medicine) ;
  • Eun, Chang-Soo (Department of Internal Medicine, Hanyang University College of Medicine) ;
  • Song, Kyu-Sang (Department of Pathology, Chungnam National University College of Medicine) ;
  • Kim, Yong-Sung (Medical Genomics Research Center, KRIBB) ;
  • Han, Dong-Soo (Department of Internal Medicine, Hanyang University College of Medicine)
  • 발행 : 2008.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives ; The objective of this study was to evaluate the prevalence of atrophic gastritis and intestinal metaplasia according to gender, age and Helicobacter pylori infection in a rural population in Korea. Methods: Between April 2003 and January 2007, 713 subjects (298 men and 415 women, age range: 18-85) among the 2,161 adults who participated in a population-based survey received gastrointestinal endoscopy. All the subjects provided informed consent. Multiple biopsy specimens were evaluated for the presence of atrophic gastritis and intestinal metaplasia. The presence of Helicobacter Pylori was determined using CLO and histology testing. Results ; The age-adjusted prevalence of atrophic gastritis was 42.7% for men and 38.1% for women and the prevalence of intestinal metaplasia was 42.5% for men and 32.7% for women. The prevalence of atrophic gastritis and intestinal metaplasia increased significantly with age for both men and women (p for trend<0.001). The age-adjusted prevalence of Helicobacter pylori was similar for men (59.0%) and women (56.7%). The subjects with Helicobacter pylori infection showed a significantly higher prevalence of intestinal metaplasia (44.3%) compared with that (26.8%) of the noninfected subjects (p<0.001). However, the prevalence of atrophic gastritis was not statistically different between the Helicobacter pylori-infected subjects and the noninfected individuals. Conclusions : Our findings suggest that the prevalence of atrophic gastritis and intestinal metaplasia is higher for a Korean rural population than that for a Western population; this may be related to the high incidence of gastric cancer in Koreans. Especially, the prevalence of intestinal metaplasia was high for the subjects with Helicobacter pylori infection. The multistep process of gastric carcinogenesis and the various factors contributing to each step of this process need to be determined by conducting future follow-up studies.

키워드

참고문헌

  1. Korea National Statistical Office. Annual Report on the Cause of Death Statistics in 2006. Korea National Statistical Office: Daejeon, 2007
  2. Shin HR, Ahn YO, Bae JM, Shin MH, Lee DH, Lee CW, et al. Cancer incidence in Korea. Cancer Res Treat 2002; 34(6): 405-408 https://doi.org/10.4143/crt.2002.34.6.405
  3. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49 https://doi.org/10.1111/apm.1965.64.1.31
  4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process: First American cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52(24): 6735-6740
  5. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 1996; 20(10): 1161-1181 https://doi.org/10.1097/00000478-199610000-00001
  6. Lauwers GY. Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and gastric adenocarcinoma. J Clin Gastroenterol 2003; 36(5 Suppl): S37-S43 https://doi.org/10.1097/00004836-200305001-00007
  7. Hartwell L, Mankoff D, Paulovich A, Ramsey S, Swisher E. Cancer biomarkers: A systems approach. Nat Biotechnol 2006; 24(8): 905-908 https://doi.org/10.1038/nbt0806-905
  8. Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, et al. Longterm sequelae of Helicobacter pylori gastritis. Lancet 1995; 345(8964): 1525-1528 https://doi.org/10.1016/S0140-6736(95)91084-0
  9. Zhang L, Blot WJ, You WC, Chang YS, Kneller RW, Jin ML, et al. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev 1996; 5(8): 627-630
  10. Ohkuma K, Okada M, Murayama H, Seo M, Maeda K, Kanda M, et al. Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia. J Gastroenterol Hepatol 2000; 15(10): 1105-1112 https://doi.org/10.1046/j.1440-1746.2000.02305.x
  11. Asaka M, Sugiyama T, Nobuta A, Kato M, Takeda H, Graham DY. Atrophic gastritis and intestinal metaplasia in Japan: Results of a large multicenter study. Helicobacter 2001; 6(4): 294-299 https://doi.org/10.1046/j.1523-5378.2001.00042.x
  12. Korean H. pylori Study Group. Diagnosis and treatment of Helicobacter pylori infection in Korea. Korean J Gastroenterol 1998; 32(3): 275-289. (Korean)
  13. International Agency for Research on Cancer. Schistosomes, Liver Flukes and Helicobacter Pylori. Geneva: WHO; 1994: p.177-240
  14. Coma del Corral MJ, Pardo-Mindan FJ, Razquin S, Ojeda C. Risk of cancer in patients with gastric dysplasia. Follow-up study of 67 patients. Cancer 1990; 65(9): 2078-2085 https://doi.org/10.1002/1097-0142(19900501)65:9<2078::AID-CNCR2820650932>3.0.CO;2-9
  15. Inoue M, Tajima K, Matsuura A, Suzuki T, Nakamura T, Ohashi K, et al. Severity of chronic atrophic gastritis and subsequent gastric cancer occurrence: A 10-year prospective cohort study in Japan. Cancer Lett 2000; 161(1): 105-112 https://doi.org/10.1016/S0304-3835(00)00603-0
  16. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004; 109(1): 138-143 https://doi.org/10.1002/ijc.11680
  17. de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, et al. Gastric cancer risk in patients with premalignant gastric lesions: A nationwide cohort study in the Netherlands. Gastroenterology 2008; 134(4): 945-952 https://doi.org/10.1053/j.gastro.2008.01.071
  18. Borch K, Jonsson KA, Petersson F, Redeen S, Mardh S, Franzen LE. Prevalence of gastroduodenitis and Helicobacter pylori infection in a general population sample: Relations to symptomatology and life-style. Dig Dis Sci 2000; 45(7): 1322-1329 https://doi.org/10.1023/A:1005547802121
  19. You WC, Zhang L, Gail MH, Li JY, Chang YS, Blot WJ, et al. Precancerous lesions in two counties of China with contrasting gastric cancer risk. Int J Epidemiol 1998; 27(6): 945-948 https://doi.org/10.1093/ije/27.6.945
  20. Namekata T, Miki K, Kimmey M, Fritsche T, Hughes D, Moore D, et al. Chronic atrophic gastritis and Helicobacter pylori infection among Japanese Americans in Seattle. Am J Epidemiol 2000; 151(8): 820-830 https://doi.org/10.1093/oxfordjournals.aje.a010282
  21. Dunn JE. Cancer epidemiology in populations of the United States--with emphasis on Hawaii and California--and Japan. Cancer Res 1975; 35(11 Pt. 2): 3240-3245
  22. Kim JH, Kim HY, Kim NY, Kim SW, Kim JG, Kim JJ, et al. Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol 2001; 16(9): 969-975 https://doi.org/10.1046/j.1440-1746.2001.02568.x
  23. Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007; 12(4): 333-340 https://doi.org/10.1111/j.1523-5378.2007.00504.x
  24. Choi KH, Lee SH, Park YH. Prevalence of Helicobacter pylori infection among Korean adults in Pusan. Korean J Gastroenterol 1996; 28(6): 758-763. (Korean)
  25. Song JB, Lee SH, Shin YM, Choi KH, Lee SD, Park YH. Seroprevalence of Helicobacter pylori infection in patients without gastric symptoms. Korean J Gastroenterol 1997; 29(2): 310-316. (Korean)
  26. Kim N. Epidemiology and transmission route of Helicobacter pylori infection. Korean J Gastroenterol 2005; 46(3): 153-158. (Korean)
  27. Replogle ML, Kasumi W, Ishikawa KB, Yang SF, Juji T, Miki K, et al. Increased risk of Helicobacter pylori associated with birth in wartime and post-war Japan. Int J Epidemiol 1996; 25(1): 210-214 https://doi.org/10.1093/ije/25.1.210
  28. Farinati F, Valiante F, Germana B, Della Libera G, Baffa R, Rugge M, et al. Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer. Eur J Cancer Prev 1993; 2(4): 321-326 https://doi.org/10.1097/00008469-199307000-00006
  29. Asaka M, Kato M, Kudo M, Katagiri M, Nishikawa K, Koshiyama H, et al. Atrophic changes of gastric mucosa are caused by Helicobacter pylori infection rather than aging: Studies in asymptomatic Japanese adults. Helicobacter 1996; 1(1): 52-56 https://doi.org/10.1111/j.1523-5378.1996.tb00008.x
  30. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a highrisk region of China: A randomized controlled trial. JAMA 2004; 291(2): 187-194 https://doi.org/10.1001/jama.291.2.187
  31. Lee Y, Jeon YC, Koo TY, Cho HS, Byun TJ, Kim TY, et al. Histological changes of gastric atrophy and intestinal metaplasia after Helicobacter pylori eradication. Korean J Gastroenterol 2007; 50(5): 299-305. (Korean)
  32. Romero-Gallo J, Harris EJ, Krishna U, Washington MK, Perez-Perez GI, Peek RM Jr. Effect of Helicobacter pylori eradication on gastric carcinogenesis. Lab Invest 2008; 88(3): 328-336 https://doi.org/10.1038/labinvest.3700719
  33. Hojo M, Miwa H, Ohkusa T, Ohkura R, Kurosawa A, Sato N. Alteration of histological gastritis after cure of Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16(11): 1923-1932 https://doi.org/10.1046/j.1365-2036.2002.01346.x
  34. Kim N, Park RY, Cho SI, Lim SH, Lee KH, Lee W, et al. Helicobacter pylori infection and development of gastric cancer in Korea: Longterm follow-up. J Clin Gastroenterol 2008; 42(5):448-454 https://doi.org/10.1097/MCG.0b013e318046eac3
  35. Miwa H, Go MF, Sato N. H. pylori and gastric cancer: The Asian enigma. Am J Gastroenterol 2002; 97(5): 1106-1112 https://doi.org/10.1111/j.1572-0241.2002.05663.x
  36. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 2000; 92(23): 1881-1888 https://doi.org/10.1093/jnci/92.23.1881
  37. Russo A, Maconi G, Spinelli P, Felice GD, Eboli M, Andreola S, et al. Effect of lifestyle, smoking, and diet on development of intestinal metaplasia in H. pylori-positive subjects. Am J Gastroenterol 2001; 96(5): 1402-1408 https://doi.org/10.1111/j.1572-0241.2001.03773.x
  38. El-Omar EM. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 2001; 48(6): 743-747 https://doi.org/10.1136/gut.48.6.743

피인용 문헌

  1. Surveillance Strategy of Atrophic Gastritis and Intestinal Metaplasia in a Country with a High Prevalence of Gastric Cancer vol.57, pp.3, 2008, https://doi.org/10.1007/s10620-011-1919-0
  2. Pathophysiology and Epidemiology of Intestinal Metaplasia vol.13, pp.2, 2013, https://doi.org/10.7704/kjhugr.2013.13.2.73
  3. Guidelines for the Diagnosis and Treatment ofHelicobacter pyloriInfection in Korea, 2013 Revised Edition vol.62, pp.1, 2008, https://doi.org/10.4166/kjg.2013.62.1.3
  4. Review of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer vol.20, pp.1, 2008, https://doi.org/10.15430/jcp.2015.20.1.25
  5. Gastric Intestinal Metaplasia Is the Most Common Histopathological Phenotype among Endoscopically Diagnosed Atrophic Gastritis Patients in North-East China vol.7, pp.2, 2008, https://doi.org/10.4236/ojgas.2017.72008
  6. Chemoprevention of Gastric Cancer: Helicobacter pylori Eradication vol.17, pp.4, 2017, https://doi.org/10.7704/kjhugr.2017.17.4.166
  7. Observation Time for Complete Endoscopy in Gastric Cancer Screening vol.18, pp.1, 2018, https://doi.org/10.7704/kjhugr.2018.18.1.13
  8. Prediagnostic Smoking and Alcohol Drinking and Gastric Cancer Survival: A Korean Prospective Cohort Study vol.73, pp.3, 2019, https://doi.org/10.4166/kjg.2019.73.3.141
  9. Gastro-duodenal disease in Africa: Literature review and clinical data from Accra, Ghana vol.25, pp.26, 2019, https://doi.org/10.3748/wjg.v25.i26.3344
  10. Chronic atrophic gastritis and intestinal metaplasia surrounding diffuse-type gastric cancer: Are they just bystanders in the process of carcinogenesis? vol.14, pp.12, 2008, https://doi.org/10.1371/journal.pone.0226427
  11. Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies vol.26, pp.19, 2008, https://doi.org/10.3390/molecules26196078